% | $
Quotes you view appear here for quick access.

Insmed Incorporated Message Board

  • terry_insmed terry_insmed Jul 31, 2014 11:43 AM Flag

    Insmed Facts for Investors

    -The breakthrough status given to NTM patients is for refractory patients only, a subset for 100k patients worldwide.
    Read the PR-
    -Iplex - the drug was dropped in 2009,all rights for the only indication showing promise was sold
    . . .by rehdvm2004 "Facts: INSM is out of the recombinant technology business. They sold all their interests "-
    --Arikayce for CF, once a 500 Million dollar opportunity! will have a limited launch and no US exposure ( the largest -most profitable market by far.)-"TOBI is being replaced by TIP anyway. TIP is Novartis. "-
    -The FDA will decide on a reg pathway soon. This is a watershed event because the abvove failed to be successful.-

    *Investing in biotech companies requires one avoid hype and false hoods about a company's position.
    The above are facts.If you are long, put protection is wise and if you are short .......- )Positioned Good Luck -

    SortNewest  |  Oldest  |  Most Replied Expand all replies
11.83-0.05(-0.42%)May 27 4:00 PMEDT